Utility of technetium-99m-sestamibi to assess osseous tumor spread.
Christian Gläser(University Clinic of Traumatology), Th. Leitha, M. Pruckmayer, Anton Staudenherz, Stefan Lang(Friedrich-Alexander-Universität Erlangen-Nürnberg), M. Rasse(University of Salzburg)
PubMed
September 1, 1996
Cited by 15
Related Papers
Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group☆ (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV
|Radiotherapy and Oncology|2005|1.6k
Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer
|Radiotherapy and Oncology|2007|541
The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: Design, application, treatment planning, and dosimetric results
|International Journal of Radiation Oncology*Biology*Physics|2006|322
Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer
|International Journal of Radiation Oncology*Biology*Physics|2005|313
A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection
|Journal of the American Society of Nephrology|2017|302